+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Hand Eczema (HE) - Epidemiology Forecast - 2032

  • PDF Icon

    Report

  • 98 Pages
  • July 2022
  • Region: Global
  • DelveInsight
  • ID: 5633019
UP TO OFF until Dec 31st 2024
This ‘Hand Eczema (HE)- Epidemiology Forecast - 2032' report delivers an in-depth understanding of Hand Eczema (HE) historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Hand Eczema (HE) Disease Understanding


Hand Eczema (HE), also known as hand dermatitis, is one of the most common types of eczema and one of the most prevalent skin conditions worldwide. It mainly affects the palms but can also affect other parts of the hand. The severity of HE may range from very mild to severe and the course from acute to chronic, resulting in prolonged disability.

Hand Eczema (HE) Epidemiology


Hand Eczema (HE) epidemiology division provides insights into the historical and incident patient pool, along with the forecasted trend for all seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The report also provides the diagnosed patient pool, trends, and assumptions.

Key Findings


The total prevalent cases of Hand Eczema (HE) patients in the 7MM are increasing during the study period, i.e., 2019-2032.

The disease epidemiology covered in the report provides historical as well as forecasted Hand Eczema (HE) symptoms epidemiology segmented as the total Prevalent cases of Hand Eczema, gender-specific cases of Hand Eczema, severity-specific cases of Hand Eczema, subgroup-specific cases of Hand Eczema, and age-specific cases of Hand Eczema. The report includes the prevalent cases scenario of Hand Eczema (HE) in 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2019 to 2032.

Country-wise Hand Eczema (HE) Epidemiology


The epidemiology segment also provides Hand Eczema (HE) epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

The prevalent cases of Hand Eczema (HE) associated in 7MM countries were around 63,300,000 in 2021.
  • As per the estimates, the United States has the largest prevalent population of Hand Eczema (HE)
Among the EU5 countries, Germany had the highest prevalent cases of Hand Eczema (HE), followed by the United Kingdom. On the other hand, Spain had the lowest prevalent cases with approximately 3,900,000 cases in 2021.

Scope of the Report

  • Hand Eczema (HE) report covers a detailed overview explaining its causes, symptoms, and classification, pathophysiology, diagnosis, and treatment patterns.
  • Hand Eczema (HE) Epidemiology Report and Model provide an overview of Hand Eczema (HE) risk factors and global trends in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
  • The report provides insight into Hand Eczema (HE) historical and forecasted patient pool in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.
  • The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
  • The report assesses the disease risk and burden and highlights the unmet needs of Hand Eczema (HE).
  • The report provides the segmentation of Hand Eczema (HE) epidemiology by the Prevalent Cases of Hand Eczema (HE) in 7MM.
  • The report provides Hand Eczema (HE) epidemiology segmentation by gender-specific cases of Hand Eczema (HE) in 7MM.
  • The report provides Hand Eczema (HE) epidemiology segmentation by severity-specific cases of Hand Eczema (HE) in 7MM.
  • The report provides Hand Eczema (HE) epidemiology segmentation by subgroup-specific cases of Hand Eczema (HE) in 7MM.
  • The report provides Hand Eczema (HE) epidemiology segmentation by age-specific cases of Hand Eczema (HE) in 7MM.

Report Highlights

  • 11-year Forecast of Hand Eczema (HE) epidemiology
  • 7MM Coverage
  • Prevalent Cases of Hand Eczema (HE)
  • Gender-specific cases of Hand Eczema (HE)
  • Severity-specific Cases of Hand Eczema (HE)
  • Subgroup-specific Cases of Hand Eczema (HE)
  • Age-specific cases of Hand Eczema (HE)

KOL Views


The publisher interviews KOLs, and SMEs' opinions through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatments by identifying the overall scenario of the indications.

Key Questions Answered

  • What are the major factors that will drive the change in the patient population in Hand Eczema (HE) during the forecast period (2019-2032)?
  • What are the key findings of Hand Eczema (HE) epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2019-2032)?
  • What would be the total number of Hand Eczema (HE) patients across the 7MM during the forecast period (2019-2032)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2019-2032)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2019-2032)?
  • What are the disease risks, burdens, and unmet needs of Hand Eczema (HE) market?
  • What are the current treatment patterns for Hand Eczema (HE)?

Reasons to Buy


Hand Eczema (HE) epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Hand Eczema (HE) market.
  • Quantify patient populations in the global Hand Eczema (HE) market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and gender that present the best opportunities for Hand Eczema (HE) therapeutics in each market covered.
  • Understand the magnitude of Hand Eczema (HE) population by its prevalence.
  • Understand the magnitude of Hand Eczema (HE) population by its gender-specific cases.
  • Understand the magnitude of Hand Eczema (HE) population by its severity-specific cases.
  • Understand the magnitude of Hand Eczema (HE) population by its subgroup-specific cases.
  • Understand the magnitude of Hand Eczema (HE) population by its age-specific cases.
  • Hand Eczema (HE) epidemiology report and model were written and developed by Master's and Ph.D. level epidemiologists.
  • Hand Eczema (HE) Epidemiology Model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports the data presented in the report and showcases disease trends over an 11-year forecast period using reputable sources.

Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan
Study Period: 2019-2032

Table of Contents

1. Key Insights2. Report Introduction
3. Hand Eczema (HE) Epidemiology Overview at a Glance
3.1. Patient Share (%) Distribution of Hand Eczema (HE) in 2019
3.2. Patient Share (%) Distribution of Hand Eczema (HE) in 2032
4. Executive Summary of Hand Eczema (HE)
5. Disease Background and Overview
5.1. Introduction
5.2. Classification
5.3. Symptoms
5.4. Risk Factors
5.5. Pathophysiology
5.6. Diagnosis
5.6.1. Diagnostic Guidelines
5.7. Differential Diagnosis
5.8. Prevention
5.9. Treatment
5.9.1. Treatment Guidelines
5.9.2. Prevention Guidelines of European Society of Contact Dermatitis (ESCD) for Hand Eczema
6. Epidemiology and Patient Population
6.1. Key Findings
6.2. 7MM Total Prevalent Population of Hand Eczema (HE)
6.3. Assumptions and Rationale
6.4. The United States
6.4.1. Total Prevalent Cases of Hand Eczema (HE) in the United States
6.4.2. Gender-specific Cases of Hand Eczema (HE) in the United States
6.4.3. Severity-specific Cases of Hand Eczema (HE) in the United States
6.4.4. Subgroup-specific Cases of Hand Eczema (HE) in the United States
6.4.5. Age-specific Cases of Hand Eczema (HE) in the United States
6.5. EU-5
6.5.1. Total Prevalent Cases of Hand Eczema (HE) in the EU-5
6.5.2. Germany
6.5.3. France
6.5.4. Italy
6.5.5. Spain
6.5.6. The United Kingdom
6.6. Japan
6.6.1. Total Prevalent Cases of Hand Eczema (HE) in Japan
6.6.2. Gender-specific Cases of Hand Eczema (HE) in Japan
6.6.3. Severity-specific Cases of Hand Eczema (HE) in Japan
6.6.4. Subgroup-specific Cases of Hand Eczema (HE) in Japan
6.6.5. Age-specific Cases of Hand Eczema (HE) in Japan
7. Patient Journey8. KOL Views
9. Appendix
9.1. Bibliography
9.2. Report Methodology
10. Publisher Capabilities11. Disclaimer12. About the Publisher
List of Tables
Table 1: Summary of Hand Eczema (HE), Epidemiology, and Key Events (2019-2032)
Table 2: Classification of Hand Eczema
Table 3: Definition of Subtypes of Hand Eczema
Table 4: Etiological Classification of Hand Eczema
Table 5: Morphological classification of Hand Eczema
Table 6: Subgroups of hand eczema and definitions
Table 7: Besides Atopic Skin Diathesis, Other Genetic Risk Factors for Hand Dermatitis Have Been Suggested
Table 8: Summary of Recommendations for the Diagnosis of HE
Table 9: Summary of Recommendations for the Treatment of HE
Table 10: Summary of Recommendations of Topical Corticosteroids for the Treatment of HE
Table 11: Summary of Recommendations of Topical Calcineurin Inhibitors for the Treatment of HE
Table 12: Summary of Recommendations for Photo-therapy for the Treatment of HE
Table 13: Summary of Recommendations of Systemic Treatment for the Treatment of HE
Table 14: Summary of Recommendations for the prevention of HE
Table 15: Total Prevalent Population of Hand Eczema in 7MM in 000s (2019-2032)
Table 16: Total Prevalent Cases of Hand Eczema in the US in 000s (2019-2032)
Table 17: Gender-specific Cases of Hand Eczema in the US in 000s (2019-2032)
Table 18: Severity-specific Cases of Hand Eczema in the US in 000s (2019-2032)
Table 19: Subgroup-specific Cases of Hand Eczema in the US in 000s (2019-2032)
Table 20: Age-specific Cases of Hand Eczema in the US, in 000s (2019-2032)
Table 21: Total Prevalent Cases of Hand Eczema in EU-5 in 000s (2019-2032)
Table 22: Gender-Specific Cases of Hand Eczema in Germany, in 000s (2019-2032)
Table 23: Severity-specific Cases of Hand Eczema in Germany, in 000s (2019-2032)
Table 24: Subgroup-specific Cases of Hand Eczema in Germany, in 000s (2019-2032)
Table 25: Age-specific Cases of Hand Eczema in Germany in 000s (2019-2032)
Table 26: Gender-specific Cases of Hand Eczema in the France in 000s (2019-2032)
Table 27: Severity-specific Cases of Hand Eczema in the France in 000s (2019-2032)
Table 28: Subgroup-specific Cases of Hand Eczema in the France, in 000s (2019-2032)
Table 29: Age-specific Cases of Hand Eczema in the France, in 000s (2019-2032)
Table 30: Gender-specific Cases of Hand Eczema in Italy in 000s (2019-2032)
Table 31: Severity-specific Cases of Hand Eczema in Italy in 000s (2019-2032)
Table 32: Subgroup-specific Cases of Hand Eczema in Italy in 000s (2019-2032)
Table 33: Age-specific Cases of Hand Eczema in Italy in 000s (2019-2032)
Table 34: Gender-specific Cases of Hand Eczema in Spain in 000s (2019-2032)
Table 35: Severity-specific Cases of Hand Eczema in Spain in 000s (2019-2032)
Table 36: Subgroup-specific Cases of Hand Eczema in Spain in 000s (2019-2032)
Table 37: Age-specific Cases of Hand Eczema in Spain in 000s (2019-2032)
Table 38: Gender-specific Cases of Hand Eczema in the UK in 000s (2019-2032)
Table 39: Severity-specific Cases of Hand Eczema in the UK, in 000s (2019-2032)
Table 40: Subgroup-specific Cases of Hand Eczema in the UK in 000s (2019-2032)
Table 41: Age-specific Cases of Hand Eczema in the UK in 000s (2019-2032)
Table 42: Total Prevalent Cases of Hand Eczema in Japan in 000s (2019-2032)
Table 43: Gender-specific Cases of Hand Eczema in Japan in 000s (2019-2032)
Table 44: Severity-specific Cases of Hand Eczema in Japan in 000s (2019-2032)
Table 45: Subgroup-specific Cases of Hand Eczema in Japan in 000s (2019-2032)
Table 46: Age-specific Cases of Hand Eczema in Japan in 000s (2019-2032)
List of Figures
Figure 1: Risk Factors for the Development of Hand Eczema
Figure 2: Etiologic diagnosis of Hand Eczema
Figure 3: Treatment options for hand eczema depending on disease severity and chronicity (based on probable efficacy, not strength of evidence)
Figure 4: Treatment algorithm for hand eczema
Figure 5: Total Prevalent Population of Hand Eczema in 000s (2019-2032)
Figure 6: Total Prevalent Cases of Hand Eczema in the US in 000s (2019-2032)
Figure 7: Gender-specific Cases of Hand Eczema in the US in 000s (2019-2032)
Figure 8: Severity-specific Cases of Hand Eczema in the US in 000s (2019-2032)
Figure 9: Subgroup-specific Cases of Hand Eczema in the US, in 000s (2019-2032)
Figure 10: Age-specific Cases of Hand Eczema in the US in 000s (2019-2032)
Figure 11: Total Prevalent Cases of Hand Eczema in the EU-5 in 000s (2019-2032)
Figure 12: Gender-specific Cases of Hand Eczema in Germany in 000s (2019-2032)
Figure 13: Severity-specific Cases of Hand Eczema in Germany in 000s (2019-2032)
Figure 14: Subgroup-specific Cases of Hand Eczema in Germany in 000s (2019-2032)
Figure 15: Age-specific Cases of Hand Eczema in Germany in 000s (2019-2032)
Figure 16: Gender-specific Cases of Hand Eczema in the France in 000s (2019-2032)
Figure 17: Severity-specific Cases of Hand Eczema in the France in 000s (2019-2032)
Figure 18: Subgroup-specific Cases of Hand Eczema in the France in 000s (2019-2032)
Figure 19: Age-specific Cases of Hand Eczema in the France in 000s (2019-2032)
Figure 20: Gender-specific Cases of Hand Eczema in Italy in 000s (2019-2032)
Figure 21: Severity-specific Cases of Hand Eczema in Italy in 000s (2019-2032)
Figure 22: Subgroup-specific Cases of Hand Eczema in Italy in 000s (2019-2032)
Figure 23: Age-specific Cases of Hand Eczema in Italy in 000s (2019-2032)
Figure 24: Gender-specific Cases of Hand Eczema in Spain in 000s (2019-2032)
Figure 25: Severity-specific Cases of Hand Eczema in Spain in 000s (2019-2032)
Figure 26: Subgroup-specific Cases of Hand Eczema in Spain in 000s (2019-2032)
Figure 27: Age-specific Cases of Hand Eczema in Spain in 000s (2019-2032)
Figure 28: Gender-specific Cases of Hand Eczema in the UK in 000s (2019-2032)
Figure 29: Severity-specific Cases of Hand Eczema in the UK in 000s (2019-2032)
Figure 30: Subgroup-specific Cases of Hand Eczema in the UK in 000s (2019-2032)
Figure 31: Age-specific Cases of Hand Eczema in the UK in 000s (2019-2032)
Figure 32: Total Prevalent Cases of Hand Eczema in Japan in 000s (2019-2032)
Figure 33: Gender-specific Cases of Hand Eczema in Japan in 000s (2019-2032)
Figure 34: Severity-specific Cases of Hand Eczema in Japan in 000s (2019-2032)
Figure 35: Subgroup-specific Cases of Hand Eczema in Japan in 000s (2019-2032)
Figure 36: Age-specific Cases of Hand Eczema in Japan in 000s (2019-2032)